Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients

E. Bultman, C. De Haar, A. Van Liere-Baron, H. Verhoog, R. L. West, E. J. Kuipers, Z. Zelinkova, C. Janneke Van Der Woude*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

110 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients'. Together they form a unique fingerprint.

Immunology and Microbiology

Keyphrases